ArticleEpilepsia open2021

Long-term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open-label trial.

Elinor Ben-Menachem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.